Insulin/adenosine axis linked signalling
MOLECULAR ASPECTS OF MEDICINE
| dc.creator | Silva, Luis | |
| dc.creator | Subiabre, Mario | |
| dc.creator | Araos, Joaquin | |
| dc.creator | Saez, Tamara | |
| dc.creator | Salsoso, Rocio | |
| dc.creator | Pardo, Fabián | |
| dc.creator | Leiva-Mendoza, Andrea Alejandra | |
| dc.creator | San Martin, Rody | |
| dc.creator | Toledo, Fernando | |
| dc.creator | Sobrevia, Luis | |
| dc.date | 2021-08-23T23:00:19Z | |
| dc.date | 2022-07-07T14:58:17Z | |
| dc.date | 2021-08-23T23:00:19Z | |
| dc.date | 2022-07-07T14:58:17Z | |
| dc.date | 2017 | |
| dc.date.accessioned | 2023-08-22T22:59:54Z | |
| dc.date.available | 2023-08-22T22:59:54Z | |
| dc.identifier | 1150344 | |
| dc.identifier | 1150344 | |
| dc.identifier | https://hdl.handle.net/10533/252823 | |
| dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/8349311 | |
| dc.description | Regulation of blood flow depends on systemic and local release of vasoactive molecules such as insulin and adenosine. These molecules cause vasodilation by activation of plasma membrane receptors at the vascular endothelium. Adenosine activates at least four subtypes of adenosine receptors (A(1)AR, A(2A)AR, A(2B)AR, A(3)AR), of which A(2A)AR and A(2B)AR activation leads to increased cAMP level, generation of nitric oxide, and relaxation of the underlying smooth muscle cell layer. Vasodilation caused by adenosine also depends on plasma membrane hyperpolarization due to either activation of intermediate-conductance Ca2+-activated K+ channels in vascular smooth muscle or activation of ATP-activated K+ channels in the endothelium. Adenosine also causes vasoconstriction via a mechanism involving A(1)AR activation resulting in lower cAMP level and increased thromboxane release. Insulin has also a dual effect causing NO-dependent vasodilation, but also sympathetic activity-and increased endothelin 1 release-dependent vasoconstriction. Interestingly, insulin effects require or are increased by activation or inactivation of adenosine receptors. This is phenomenon described for D-glucose and L-arginine transport where A(2A)AR and A(2B)AR play a major role. Other studies show that A(1)AR activation could reduce insulin release from pancreatic beta-cells. Whether adenosine modulation of insulin biological effect is a phenomenon that depends on co-localization of adenosine receptors and insulin receptors, and adenosine plasma membrane transporters is something still unclear. This review summarizes findings addressing potential involvement of adenosine receptors to modulate insulin effect via insulin receptors with emphasis in the human vasculature. (C) 2016 Elsevier Ltd. All rights reserved. | |
| dc.description | Regular 2015 | |
| dc.description | FONDECYT | |
| dc.description | FONDECYT | |
| dc.language | eng | |
| dc.relation | handle/10533/111557 | |
| dc.relation | handle/10533/111541 | |
| dc.relation | handle/10533/108045 | |
| dc.relation | https://doi.org/10.1016/j.mam.2016.11.002 | |
| dc.rights | Atribución-NoComercial-SinDerivadas 3.0 Chile | |
| dc.rights | http://creativecommons.org/licenses/by-nc-nd/3.0/cl/ | |
| dc.rights | info:eu-repo/semantics/article | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.title | Insulin/adenosine axis linked signalling | |
| dc.title | MOLECULAR ASPECTS OF MEDICINE | |
| dc.type | Articulo | |
| dc.type | info:eu-repo/semantics/publishedVersion |